These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23427187)

  • 1. Improvement of nanoprecipitation technique for preparation of gelatin nanoparticles and potential macromolecular drug loading.
    Khan SA; Schneider M
    Macromol Biosci; 2013 Apr; 13(4):455-63. PubMed ID: 23427187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin nanoparticles for NSAID systemic administration: Quality by design and artificial neural networks implementation.
    Koletti AE; Tsarouchi E; Kapourani A; Kontogiannopoulos KN; Assimopoulou AN; Barmpalexis P
    Int J Pharm; 2020 Mar; 578():119118. PubMed ID: 32032642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatin nanoparticle preparation by nanoprecipitation.
    Lee EJ; Khan SA; Lim KH
    J Biomater Sci Polym Ed; 2011; 22(4-6):753-71. PubMed ID: 20566056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation.
    Lee EJ; Khan SA; Park JK; Lim KH
    Bioprocess Biosyst Eng; 2012 Jan; 35(1-2):297-307. PubMed ID: 21909678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
    Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M
    Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
    Abozeid SM; Hathout RM; Abou-Aisha K
    Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI.
    Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J
    Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles.
    Nimesh S; Manchanda R; Kumar R; Saxena A; Chaudhary P; Yadav V; Mozumdar S; Chandra R
    Int J Pharm; 2006 Oct; 323(1-2):146-52. PubMed ID: 16920286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical properties of gelatin nanoparticles in dependency of crosslinking time and storage.
    Weiss AV; Fischer T; Iturri J; Benitez R; Toca-Herrera JL; Schneider M
    Colloids Surf B Biointerfaces; 2019 Mar; 175():713-720. PubMed ID: 30612047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospinning of PVA/chitosan nanocomposite nanofibers containing gelatin nanoparticles as a dual drug delivery system.
    Fathollahipour S; Abouei Mehrizi A; Ghaee A; Koosha M
    J Biomed Mater Res A; 2015 Dec; 103(12):3852-62. PubMed ID: 26112829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatin Nanoparticles with Enhanced Affinity for Calcium Phosphate.
    Farbod K; Diba M; Zinkevich T; Schmidt S; Harrington MJ; Kentgens AP; Leeuwenburgh SC
    Macromol Biosci; 2016 May; 16(5):717-29. PubMed ID: 26773715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of gelatin nano/submicron particles by binary nonsolvent aided coacervation (BNAC) method.
    Patra S; Basak P; Tibarewala DN
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():310-318. PubMed ID: 26652378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts.
    Gupta AK; Gupta M; Yarwood SJ; Curtis AS
    J Control Release; 2004 Mar; 95(2):197-207. PubMed ID: 14980768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatin Nanoparticles.
    Hathout RM; Metwally AA
    Methods Mol Biol; 2019; 2000():71-78. PubMed ID: 31148009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats.
    Yoshikawa Y; Komuta Y; Nishihara T; Itoh Y; Yoshikawa H; Takada K
    J Drug Target; 1999; 6(6):449-61. PubMed ID: 10937290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human gelatin nanoparticles as a protein drug carrier.
    Won YW; Kim YH
    J Control Release; 2008 Apr; 127(2):154-61. PubMed ID: 18329122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of gelatin nanoparticles without crosslinking.
    Khan SA; Schneider M
    Macromol Biosci; 2014 Nov; 14(11):1627-38. PubMed ID: 25154300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.